Q2 2022 13F Holders as of 30 Jun 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
69,402,414
-
Share change
-
-8,294,628
-
Total reported value
-
$34,700,000
-
Price per share
-
$0.50
-
Number of holders
-
41
-
Value change
-
-$5,025,883
-
Number of buys
-
13
-
Number of sells
-
45
Institutional Holders of AVALO THERAPEUTICS INC - COM (AVTX) as of Q2 2022
As of 30 Jun 2022,
AVALO THERAPEUTICS INC - COM (AVTX) was held by
41 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
69,402,414 shares.
The largest 10 holders included
ARMISTICE CAPITAL, LLC, Nantahala Capital Management, LLC, Point72 Asset Management, L.P., VANGUARD GROUP INC, BlackRock Inc., MILLENNIUM MANAGEMENT LLC, GEODE CAPITAL MANAGEMENT, LLC, GOLDMAN SACHS GROUP INC, Opaleye Management Inc., and RENAISSANCE TECHNOLOGIES LLC.
This page lists
41
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.